AUDIO-Momentum is there for biogenerics in US: Teva

November 15, 2007

barrett.jpgBiogenerics in the U.S. will happen — it’s just a matter of when, according to Teva Pharmaceuticals’ head of North America.

George Barrett told the Reuters Health Summit that while next year is a toss-up given it’s an election year, setting up the regulatory pathway for biogeneirics to get to market is critical in the next two years ahead of wave of patents due to expire in five years.

Barrett was one of the featured speakers in the final day of the annual Reuters Health Summit speaking from our New York headquarters.

No comments so far

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see